![The Synthesis of (−)-4-Methyl-8-Chloro-Trans-1,2,3,4,4a,5,6,10b-Octahydrobenzo-[f]-Quinolin-3-One-[3-14C] (LY300502-14C) via a Circuitous Route](/images/research/73bab8dc-bdf0-45e3-8ef7-73d0d4b93cb1/small/21074.jpg)
research The Synthesis of (−)-4-Methyl-8-Chloro-Trans-1,2,3,4,4a,5,6,10b-Octahydrobenzo-[f]-Quinolin-3-One-[3-14C] (LY300502-14C) via a Circuitous Route
Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.
Search
for
Sort by
Research
450-480 / 1000+ results 
research Platelet-Rich Plasma with Low Dose Oral Minoxidil (1.25 mg Versus 2.5 mg) Along with Trichoscopic Pre- and Post-Treatment Evaluation
Combining platelet-rich plasma therapy with low dose oral minoxidil improved hair growth in men with hair loss, with slightly higher satisfaction at the higher minoxidil dose.
research Comparative Study of the Efficacy and Safety of Topical Minoxidil 2% Versus Topical Bimatoprost 0.01% Versus Topical Bimatoprost 0.03% in Treatment of Eyebrow Hypotrichosis: A Randomized Controlled Trial
Bimatoprost 0.03% is as effective as minoxidil 2% for eyebrow growth.
research The Clinical Course and Outcomes of SARS-CoV-2 Virus Infection in Children: A 24-Week Follow-Up Study in Sulaimaniyah, Iraq
Most children recovered from COVID-19 in 4 weeks, but some experienced long-term symptoms, especially older kids.
research OsCSLD1 Mediates NH4+-Dependent Root Hair Growth Suppression and AMT1;2 Expression in Rice
CSLD1 suppresses rice root hair growth with NH4+ and regulates AMT1;2 expression.
research Response to Baricitinib in the Treatment of Patients with Early and Late Onset Alopecia Areata in the Phase 2 Portion of BRAVE-AA1 Randomized Controlled Trial
Baricitinib was effective in treating both early and late onset alopecia areata.
research Efficacy and Safety of Once-Daily Minoxidil Foam 5% Versus Twice-Daily Minoxidil Solution 2% in Female Pattern Hair Loss: A Phase III, Randomized, Investigator-Blinded Study
Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.
research A Practitioner's Guide to Hair Loss: Part 2—Diet, Supplements, Vitamins, Minerals, Aromatherapy, and Psychosocial Aspects
Non-drug methods like diet, supplements, and aromatherapy can help manage hair loss and its emotional impact.
research Research Progress of Post-Acute Sequelae After SARS-CoV-2 Infection
Long COVID causes various long-term health issues and needs better awareness and treatment.
research Essential Oils-Based Nanoemulsion Formulation Boosts Hair Growth in C57BL/6 Mice Compared to Minoxidil 2%
Essential oils in a nanoemulsion help hair grow better than minoxidil 2% in mice.
research Navigating Hair Loss in Medical School: Experiences of Two Young Black Women
Dermatologists need better training on Black hair to improve care and outcomes.
research Impact of the SARS-CoV-2 Pandemic on Climacteric Women's Health: Websurvey
The pandemic worsened mental health and healthcare access for middle-aged women, leading to negative changes in their lifestyle.
research Sex-Related Differences in the Pharmacological Response in SARS-CoV-2 Infection, Dyslipidemia, and Diabetes Mellitus: A Narrative Review
Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.
research Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes
Women with Polycystic Ovary Syndrome (PCOS) have a higher risk of developing type 2 diabetes due to insulin resistance.
research The Science of Aging, Part 2 Supplement
The document's conclusion cannot be provided because the document is not accessible or understandable.
research Introduction to Science of Aging, Part 2
I'm sorry, but I can't provide a conclusion without the content of the document.
research Current Issue: Vol. 2 No. 4 (2021) Pages 1-67
Laparoscopic cholecystectomy has aesthetic benefits, and maskne became common during COVID-19.
research Side Effects of Sodium Valproate Among Children With Epilepsy Under 2 Years of Age
Sodium valproate caused vomiting, hair loss, loss of appetite, abdominal pain, weight gain, and anemia in young children with epilepsy.
research Computational Screening of Repurposed Drugs and Natural Products Against SARS-CoV-2 Main Protease as Potential COVID-19 Therapies
Some existing drugs and natural products might work against COVID-19 by targeting the virus's main protease.
research Ultrasound-Assisted Facile Synthesis and Anticancer Evaluation of Novel N-(2-Substituted Phenyl-4-Oxathiazolidine-3-Carbonothioyl) Benzamide
Researchers made new compounds that could potentially be developed into anticancer drugs.
research Peer Review of Computational Drug Repositioning Based on Side-Effects Mined from Social Media
The study improved and was accepted despite initial concerns about data clarity, methodology, and potential overfitting.
research Case Report: Two Instances of Drug Eruption Caused by Bortezomib Presenting as Multiple Plaques on the Trunk
Bortezomib chemotherapy can cause temporary skin rashes.
research Contents Volume 2, 2016
The document discusses various nail and hair disorders and their treatments.
research Clinical Quiz No. 2: Dermatophycosis in Animals
Dermatophycosis is a treatable fungal skin infection spread by contact with infected animals.
research Alopecia Areata During Pegylated Interferon Alpha2a Treatment in Chronic Hepatitis B Patients
A hepatitis B patient lost hair in patches after starting and stopping a treatment with pegylated interferon alpha2a.
research Studies on a Hair Growth Stimulant, Procyanidin B-2
research Review: Special Issue on Hair Restoration; The American Journal of Cosmetic Surgery Vol. 14, No. 2, 1997
I'm sorry, but I can't provide a summary as I don't have access to the specific content of the document.
research Efficacy and Safety of ENERGI-F701 Solution Versus 2% Minoxidil Solution for Female Pattern Hair Loss: A Phase II, Multi-Center, Randomized, Double-Blind, Head-to-Head, Parallel Trial
research Efficacy and Safety of ENERGI-F701 Solution Versus 2% Minoxidil Solution for Female Pattern Hair Loss: A Phase II, Multi-Center, Randomized, Double-Blind, Head-to-Head, Parallel Trial
ENERGI-F701 solution was found to be more effective and safer than Regaine® 2% minoxidil solution in treating female pattern hair loss, with increased hair density and less side effects.